(E)-1-(3,4-methylenedioxyphenyl)-3-(2,3,4-trimethoxy-phenyl)prop-2-en-1-one | 1352444-91-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-1-(3,4-methylenedioxyphenyl)-3-(2,3,4-trimethoxy-phenyl)prop-2-en-1-one
• 英文别名: (2E)-1-(1',3'-benzodioxol-5-yl)-3-(2,3,4-trimethoxyphenyl)-2-propen-1-one；(2E)-1-(1,3-benzodioxol-5-yl)-3-(2,3,5-trimethoxyphenyl)-2-propen-1-one；(E)-1-(1,3-benzodioxol-5-yl)-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one
• CAS: 1352444-91-7
• 化学式: C₁₉H₁₈O₆
• 分子量: 342.348
• InChiKey: FSIMGKYEOKOUSI-QPJJXVBHSA-N

物化性质

• 沸点：
  515.8±50.0 °C(Predicted)
• 密度：
  1.253±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  63.2
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  3,4-亚甲二氧苯乙酮 、 2,3,4-三甲氧基苯甲醛 在 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 以67%的产率得到(E)-1-(3,4-methylenedioxyphenyl)-3-(2,3,4-trimethoxy-phenyl)prop-2-en-1-one
  参考文献：
  名称：

  The Synthesis of Chalcones as Anticancer Prodrugs and their Bioactivation in CYP1 Expressing Breast Cancer Cells

  摘要：

  背景：尽管许多 P450 在肿瘤和相应正常组织中的表达水平不同，CYP1B1 是少数在肿瘤中显著且一致过表达的 CYP 亚家族之一。研究表明，CYP1B1在肿瘤中具有活性，并且能够代谢结构多样的抗癌药物。因此，以及其在激活前致癌物中的作用，CYP1B1 被视为抗癌药物开发的重要靶点。 目标：基于化学预防剂 DMU-135 合成一系列查尔酮衍生物，并研究它们在表达 CYP1B1 和 CYP1A1 的人乳腺癌细胞系中的抗增殖活性。 方法：通过克来森-施密特缩合反应合成了产率为 43-94%的一系列查尔酮。这些化合物通过 MTT assay 对一组已知 CYP1 表达的乳腺癌细胞系进行了筛选。 结果：许多衍生物在表达 CYP1B1 和 CYP1A1 的人乳腺癌细胞系中显示出有前景的抗增殖活性，同时对没有 CYP 表达的非肿瘤乳腺癌细胞系显示出显著较低的毒性。使用 CYP1抑制剂 acacetin 和 α-naphthoflavone 的实验为这些化合物在生物激活过程中涉及 CYP1 酶提供了支持性证据。 结论：查尔酮作为抗癌药物显示出潜力，有证据表明这些化合物的 CYP1 激活可能参与其中。

  DOI：

  10.2174/1573406414666180112120134

文献信息

• Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors
  作者：Lívia B. Salum、Wanessa F. Altei、Louise D. Chiaradia、Marlon N.S. Cordeiro、Rafael R. Canevarolo、Carolina P.S. Melo、Evelyn Winter、Bruno Mattei、Hikmat N. Daghestani、Maria Cláudia Santos-Silva、Tânia B. Creczynski-Pasa、Rosendo A. Yunes、José A. Yunes、Adriano D. Andricopulo、Billy W. Day、Ricardo J. Nunes、Andreas Vogt

  DOI：10.1016/j.ejmech.2013.02.037

  日期：2013.5

  Based on classical colchicine site ligands and a computational model of the colchicine binding site on beta tubulin, two classes of chalcone derivatives were designed, synthesized and evaluated for inhibition of tubulin assembly and toxicity in human cancer cell lines. Docking studies suggested that the chalcone scaffold could fit the colchicine site on tubulin in an orientation similar to that of the natural product. In particular, a 3,4,5-trimethoxyphenyl ring adjacent to the carbonyl group appeared to benefit the ligand-tubulin interaction, occupying the same subcavity as the corresponding moiety in colchicine. Consistent with modeling predictions, several 3,4,5-trimethoxychalcones showed improved cytotoxicity to murine acute lymphoblastic leukemia cells compared with a previously described parent compound, and inhibited tubulin assembly in vitro as potently as colchicine. The most potent chalcones inhibited the growth of human leukemia cell lines at nanomolar concentrations, caused microtubule destabilization and mitotic arrest in human cervical cancer cells, and inhibited human breast cancer cell migration in scratch wound and Boyden chamber assays. (C) 2013 Elsevier Masson SAS. All rights reserved.
• Synthesis, Biological Evaluation, And Molecular Modeling of Chalcone Derivatives As Potent Inhibitors of Mycobacterium tuberculosis Protein Tyrosine Phosphatases (PtpA and PtpB)
  作者：Louise Domeneghini Chiaradia、Priscila Graziela Alves Martins、Marlon Norberto Sechini Cordeiro、Rafael Victorio Carvalho Guido、Gabriela Ecco、Adriano Defini Andricopulo、Rosendo Augusto Yunes、Javier Vernal、Ricardo José Nunes、Hernán Terenzi

  DOI：10.1021/jm2012062

  日期：2012.1.12

  Tuberculosis (TB) is a major infectious disease caused by Mycobacterium tuberculosis (Mtb). According to the World Health Organization (WHO), about 1.8 million people die from TB and 10 million new cases are recorded each year. Recently, a new series of naphthylchalcones has been identified as inhibitors of Mtb protein tyrosine phosphatases (PTPs). In this work, 100 chalcones were designed, synthesized, and investigated for their inhibitory properties against MtbPtps. Structure-activity relationships (SAR) were developed, leading to the discovery of new potent inhibitors with IC50 values in the low-micromolar range. Kinetic studies revealed competitive inhibition and high selectivity toward the Mtb enzymes. Molecular modeling investigations were carried out with the aim of revealing the most relevant structural requirements underlying the binding affinity and selectivity of this series of inhibitors as potential anti-TB drugs.